Search
for
Sort by
Research 151–180 of 1000+
- Therapies
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Current management strategies for cutaneous T-cell lymphoma
- Regulation of VDR by ΔNp63α is associated with inhibition of cell invasion
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- A Combinatorial Tweet Clustering Methodology Utilizing Inter and Intra Cosine Similarity
- Dermatoses of pregnancy
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Dermatological adverse events with taxane chemotherapy
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Pseudoacromegaly induced by the long-term use of minoxidil
- Update on the dermatologic use of systemic glucocorticosteroids
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Pemphigus and associated comorbidities: a cross-sectional study
- Madarosis
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Psychodermatology
- Topical absorption and systemic toxicity
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Minoxidil overdose with ecg changes: Case report and review
- Dermatologic Reactions to Targeted Therapy
- Topical minoxidil sensitization in androgenic alopecia
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Herbal Treatment for Dermatologic Disorders
- Case report: pemphigus vulgaris in an adolescent
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases